$0.57
-4.9%DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.
Strong working capital position provides significant operational flexibility and financial cushion.
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
DCGO โข NASDAQ
| DocGo Inc. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
ASSETS | |||||||
CURRENT ASSETS | |||||||
51M | 89.2M | 59.3M | 157.3M | 175.5M | 32.4M | 47.7M | |
51M | 89.2M | 59.3M | 157.3M | 175.5M | 32.4M | 47.7M | |
92.9M | 210.9M | 262.1M | 103M | 78.4M | 24.9M | 10.2M | |
92.9M | 210.9M | 262.1M | 103M | 78.4M | 24.9M | 10.2M | |
0.0 | 0.0 | 0.0 | 4.5M | 0.0 | 0.0 | 0.0 | |
4.8M | 0.0 | 0.0 | 0.0 | 2.1M | 1.2M | 1.2M | |
3.7M | 4.3M | 17.5M | 6.3M | 0.0 | 1.0 | 0.0 | |
152.4M | 304.5M | 338.9M | 271.1M | 256M | 58.4M | 59.1M | |
NON-CURRENT ASSETS | |||||||
43.5M | 42.2M | 38.4M | 39.4M | 26.2M | 21.1M | 20.4M | |
0.0 | 47.4M | 47.5M | 38.9M | 8.7M | 6.6M | 6.3M | |
0.0 | 25.7M | 37.7M | 23M | 10.7M | 10.7M | 10M | |
0.0 | 73.2M | 85.2M | 61.9M | 19.4M | 17.3M | 16.3M | |
0.0 | 5.5M | 553.6K | 598K | 589.1K | 0.0 | 0.0 | |
538.9K | 8.4M | 11.9M | 10M | 0.0 | 0.0 | 0.0 | |
20.7M | 21.8M | 15.5M | 10.4M | 7.4M | 3.4M | 5.1M | |
64.7M | 151.1M | 151.6M | 122.2M | 53.6M | 41.7M | 41.8M | |
217.1M | 455.6M | 490.5M | 393.3M | 309.6M | 100.2M | 101M | |
LIABILITIES | |||||||
CURRENT LIABILITIES | |||||||
11.4M | 28.4M | 27.7M | 21.6M | 15.8M | 4M | 947.9K | |
11.1M | 28.4M | 19.8M | 21.6M | 15.8M | 4M | 947.9K | |
337K | 28.7K | 7.8M | 0.0 | 0.0 | 0.0 | 0.0 | |
21.9M | 27.5M | 71.3M | 23.5M | 24.8M | 11.8M | 4.4M | |
51.7K | 30M | 25M | 664.9K | 626.3K | 664.4K | 564.9K | |
10.2M | 8.5M | 6.3M | 5.1M | 4.7M | 3.5M | 3.1M | |
23.9M | 27.4M | 39.8M | 49.4M | 11.9M | 3.6M | 680.5K | |
67.5M | 121.8M | 170.1M | 100.2M | 57.9M | 23.5M | 9.7M | |
NON-CURRENT LIABILITIES | |||||||
183.8K | 5.2K | 41.6K | 1.2M | 1.3M | 594.5K | 751.5K | |
4.8M | 0.0 | 0.0 | 0.0 | 13.5M | 0.0 | 0.0 | |
23.7M | 18.6M | 15.2M | 14.2M | 24.7M | 9.7M | 11.9M | |
28.9M | 27.2M | 21.4M | 18M | 14.6M | 12.6M | 14.2M | |
91.2M | 140.4M | 185.3M | 114.4M | 82.5M | 33.2M | 21.6M | |
SHAREHOLDERS' EQUITY | |||||||
9.9K | 10.2K | 10.4K | 10.2K | 10K | 0.0 | 0.0 | |
325.4M | 321.1M | 320.7M | 301.5M | 283.2M | 142.3M | 141.7M | |
-183.8M | -1.4M | -21.4M | -29M | -63.6M | -87.3M | -72.9M | |
2.4M | 1.2M | 1.5M | 741.2K | -32.5K | -48.5K | -244.9K | |
144M | 320.9M | 300.8M | 273.2M | 219.6M | 55M | 68.5M | |
125.9M | 315.2M | 305.2M | 278.9M | 227.1M | 66.9M | 79.4M | |
-18.1M | -5.7M | 4.4M | 5.7M | 7.5M | 11.9M | 10.9M | |
SUMMARY | |||||||
217.1M | 455.6M | 490.5M | 393.3M | 309.6M | 100.2M | 101M | |
0.0 | 5.5M | 553.6K | 598K | 589.1K | 0.0 | 0.0 | |
29.2M | 57.2M | 46.5M | 19.9M | 16.5M | 13.9M | 15.5M | |
-21.8M | -32.1M | -12.8M | -137.4M | -159M | -18.5M | -32.2M | |
97,808,137 | 97,808,137 | 97,808,137 | 97,808,137 | 97,808,137 | 97,808,137 | 97,808,137 |
DCGO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 11, 2026 | May 11, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 11, 2026 | March 31, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 16, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 22, 2026 | April 17, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 16, 2026 | March 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 16, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | January 30, 2026 | January 26, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 12, 2025 | December 12, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 10, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 10, 2025 | November 10, 2025 | 2025 |
Continue your DCGO research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.